2021 eContouring for Hematologic Malignancies Webinar
To access the Live event - Click on take course and then navigate past the homework to the Join the Webinar link.
Radiotherapy use in hematologic malignancies requires judicial use and very thorough understanding of the contours, techniques for treatment and doses to organs at risk. Therefore, identifying and delineating the correct anatomic regions in the target volumes is critical, and incorrectly identified target regions could lead to long term treatment related sequelae.
In this session, learners will review 3 cases of hematologic malignancies. They will be assigned specific images from a treatment planning scan and will provide contours of target volumes that will be compared to other learners as well as the faculty’s contours.
This webinar was sponsored by the ROI Juan A. del Regato Fund.
This program is designed to meet the interest of radiation oncologists and radiation oncology residents.
Upon completion of this activity, participants should be able to:
- Delineate the appropriate target volumes for mediastinal radiotherapy.
- Delineate the appropriate organ at risk volumes/constraints for mediastinal radiotherapy.
- Delineate the appropriate target volumes for extranodal MALT lymphomas.
- Delineate the appropriate target volumes for low-grade non-Hodgkin lymphomas.
Leslie Ballas, MD, is employed at USC and has no financial relationships with a commercial interest.
Rahul Parikh, MD, is employed by Rutgers Cancer Institute of New Jersey and received financial compensation (honoraria) from Mevion Medical Systems.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $149.00
- Member: $99.00
- This webinar is free to members-in-training.
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.